Rotator Cuff Injury Treatment Market in terms of revenue was estimated to be worth $989.3 million in 2021 and is poised to reach $1,244.2 million by 2026, growing at a CAGR of 4.7% from 2021 to 2026 according to a latest report published by MarketsandMarkets™. Various factors such as rising number of sports-related shoulder injuries, technological advancements in rotator cuff rupture arthroscopic surgical devices, greater product affordability and market availability, and growing public awareness related to the availability of different treatments for rotator cuff rupture. Moreover, the ongoing developments in regenerative biologics are likely to offer significant growth opportunities for players in the rotator cuff injury treatment market.

rotator-cuff-injury-treatment-market.jpg

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=71095820

Rotator Cuff Injury Treatment Market Dynamics

Driver: Rising number of sports-related shoulder injuries

Sports and shoulder-related physical activities can cause high stress on the shoulder leading to the development of rotator cuff tendonitis, resulting in shoulder pain and weakness, further limiting the movement of the arm. The upper extremities constitute one-third of the proportion of sports injuries. Athletes engaged in sports like baseball, tennis, handball, and volleyball experience an acute episode of trauma or such as falling. Such episodes can increase the severity of shoulder injuries, ranging from rotator cuff contusions and tendinopathies development in rotator cuff tears. Around 3.5 million sports injuries are registered in the US annually (Source: National Electronic Injury Surveillance System, data as of 2019).

Restraint: High costs associated with arthroscopic surgical procedures

The high cost of arthroscopic surgery is a major concern, especially in emerging markets like China and India, where only a smaller population is under insurance coverage. The average cost of outpatient shoulder arthroscopy treatment in India can range between USD 3000 to USD 5000. Such costly treatments have reduced the affordability of shoulder arthroscopy are limiting the growth of this market. Moreover, surgical settings across low resource income nations are highly reluctant to adopt novel products owing to a lack of awareness and affordability, thus expecting to hinder the growth of this market to a certain extent.

Opportunity: Novel orthobiologics in pipeline

Regenerative biologics is a rapidly growing segment that is anticipated to change the facet of sports orthopedics significantly. Despite the development of advanced sutures, the high failure rates encourage many researchers to opt for biological therapy to stimulate the healing of an injury. Many players such as Nephew, Zimmer, Johnson & Johnson (through its DePuy Division), and Stryker are strongly shifting their focus on expanding their product offering in this domain. Moreover, the emergence of many new players in the development of innovative regenerative biologics is likely to result in potentially promising treatment options for rotator cuff injuries.

For instance: In March 2020, Ortho Regenerative Technologies Inc. announced the positive results from a pivotal preclinical study of ORTHO-R Biopolymer. This mucoadhesive CHITOSAN-based biopolymer matrix acts as a biodegradable scaffold. It is mixed with the patients PRP to develop biologics which further aids in increasing the healing rates of tendon relator injuries. With continued advanced development in orthobiologics, invasive orthopedic surgeries are expected to shift towards a minimally invasive treatment approach that offers high tendon healing rates

Challenge: High failure rates of rotator cuff surgical treatment

The incidence of rotator cuff injuries is increasing and requires immediate surgical intervention to repair the tear. However, there is still a growing failure rate in the surgical treatment of rotator cuffs, thus being a major concern. Despite improvements in rotator cuff surgery techniques, the chances of re-tear rate remain above 20%, increasing with the severity of the tear, hindering the overall growth of the global market.

The surgical or curative treatment to capture the largest share in rotator cuff injury treatment industry, by type during the forecast period.

The surgical treatment segment is expected to hold the largest share of the rotator cuff injury treatment market, during the forecast period. This is attributable to the high adoption due to the increasing prevalence of rotator cuff injuries majorly among sportspersons and the availability of medical reimbursements for surgical treatment for rotator cuff rupture in the developed nations.

Additionally, the increase in the preference of shoulder arthroscopy for the treatment rotator cuff tear among surgeons and the growing awareness about the benefits associated with an arthroscopic repair such as lower risk of complications, quick recovery, low rate of post surgical infections are likely to play a significant role in propelling the growth of the segment.

Request 10% Customization:

https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=71095820

North America is the largest regional market for rotator cuff injury treatment industry

North America capture the largest share of the rotator cuff injury treatment market. This is attributed to the continuous development and commercialization of novel rotator cuff injury treatment products, favorable reimbursement and insurance coverage for rotator cuff repair treatment, supportive government regulations for product commercialization, and significant participation in sports.

Additionally, the growing adoption of bracing products for preventive and post-operative patient care, and strong presence of several key players in the country with its orthobiologic products in pipeline are likely to contribute towards the dominant market position.

The prominent players operating in this market includes Arthrex (US), Stryker Corporation (US), Smith & Nephew (UK), Johnson & Johnson (DePuy Synthes) (US), Zimmer Biomet (US), CONMED Corporation (US), Integra LifeSciences Corporation (US), LimaCorporate (Italy), FH ORTHOPEDICS S.A.S. (France), Evolutis India Pvt Ltd. (India), DJO Global (US), 3S Ortho (France), Breg, Inc. (US), GPC Medical Ltd. (India), and Parcus Medical (US).

Smith & Nephew

Smith & Nephew is one of the leading global producers of advanced wound management, arthroscopy, trauma and clinical therapy, and orthopedic reconstruction products. The company operates in more than 100 countries across the Americas, Africa, Asia, Australasia, Europe, and the Middle East. The company’s geographic presence is divided into established and emerging markets, where the established markets consist of the US, Canada, Australia, Europe, Japan, and New Zealand. The company has an advanced integrated deep global distribution network in the shoulder arthroscopic product category.

ARTHREX

Arthrex is a German-based medical device company that is engaged in the development and manufacture of the shoulder, knee, elbow, hand & wrist, foot & ankle, hip, and related products, orthobiologics, and imaging & resection products. The company commercializes its products directly and through a wide network of distributors in the Americas, Europe, the Middle East, Africa, and Asia. Arthrex is headquartered in Naples, Florida, the US. With the successful launch of the shoulder arthroscopy system in the US, the company strengthened its geographical footprint across North America, further increasing its customer base by offering advanced treatment options to patients undergoing treatment for rotator cuff tears.

Stryker Corporation

Stryker Corporation is one of the leading providers of highly innovative medical products and services in orthopedics, medical and surgical, and neurotechnology and spine fields. The company is adopting various organic and inorganic growth strategies to maintain its position in the market. Acquisitions, the continuous launch of innovative products for rotator cuff tear treatment, and participation in national and international conferences offer growth opportunities for the company to enhance its brand presence across the globe.

Recent Developments:

  • In 2021, Stryker announced the acquisition of OrthoSpace, Ltd., with an aim to enlarge its sports medicine product offerings, including surgical products for rotator cuff tear treatment.
  • In 2021, DePuy Synthes announced the launch of Inhance, a fully integrated shoulder arthroplasty system.
  • In 2021, Smith & Nephew announced the launch of a knotless suture, Healicoil, used during the arthroscopic treatment of rotator cuff rupture.

Top 3 Use Cases of Rotator Cuff Injury Treatment Market:

  • Arthroscopic Repair: Arthroscopic surgery is a minimally invasive approach that has become a widely adopted technique for treating rotator cuff injuries. It involves the use of small incisions and specialized instruments to repair the torn tendons of the rotator cuff. Arthroscopic repair offers benefits such as reduced postoperative pain, faster recovery, and improved cosmetic outcomes. This technique is commonly used for smaller to moderate-sized tears and has proven to be effective in restoring shoulder function.
  • Regenerative Medicine: The use of regenerative medicine approaches, such as stem cell therapy and tissue engineering, shows promise in the treatment of rotator cuff injuries. Stem cells can be harvested from the patient's own body or from other sources and then introduced into the damaged area to promote tissue healing and regeneration. Tissue engineering involves the creation of scaffolds or matrices that provide structural support and promote tissue growth. These regenerative approaches aim to enhance the body's natural healing process and may offer improved outcomes, particularly for more severe or chronic rotator cuff injuries.
  • Rehabilitation and Physical Therapy: Rehabilitation and physical therapy play a crucial role in the comprehensive treatment of rotator cuff injuries. Following surgical intervention or conservative management, a tailored rehabilitation program helps restore strength, flexibility, and function of the shoulder joint. It involves a range of exercises, manual therapy techniques, and modalities that target the rotator cuff muscles and associated structures. Rehabilitation aims to optimize recovery, improve range of motion, and prevent re-injury. It is an essential component of the overall treatment plan for rotator cuff injuries, enabling patients to regain functional independence and return to their daily activities.
  • These three use cases highlight the comprehensive approach to treating rotator cuff injuries, incorporating surgical intervention, regenerative medicine approaches, and rehabilitative care. By leveraging these strategies, healthcare professionals can effectively address the various aspects of rotator cuff injuries, promoting healing, restoring function, and improving patient outcomes.

Report Link: ( Rotator cuff treatment market )

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: 1-888-600-6441

Email: sales@marketsandmarkets.com

Research Insight: https://www.marketsandmarkets.com/ResearchInsight/rotator-cuff-injury-treatment-market.asp

Visit Our Web Site: https://www.marketsandmarkets.com

Content Source:  https://www.marketsandmarkets.com/PressReleases/rotator-cuff-injury-treatment.asp

https://www.globenewswire.com/en/news-release/2023/05/11/2666712/0/en/Rotator-Cuff-Injury-Treatment-Market-is-Expected-to-Reach-1-244-2-million-MarketsandMarkets.html